VB10.NEO: Development of a Personalized DNA-based Vaccine to Treat a Range of Cancers

Time: 4:15 pm
day: Day One


• Industry collaboration to generate individualized cancer treatments intended for use as a therapeutic vaccination in patient with locally advanced or metastatic tumors
• Clinical data to show a clear link between selection of high-quality neoepitopes and generation of strong neoepitope-specific CD8+ T cell responses